BioSpace News Archive

Business

Vericel Enters into Exclusive License Agreement with MediWound for North American Rights to NexoBrid, a Biological Orphan Product for Debridement of Severe Thermal Burns

Vericel Corporation announced that it has entered into exclusive license and supply agreements with MediWound Ltd. to commercialize NexoBrid® in North America. NexoBrid is a topically-administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours of application without harming viable tissue.

May 7, 2019
·
9 min read
Pharm Country

2019 Lupus Luminary Luncheon for Science Celebrates Women of Achievement for Lupus Awareness Month

The 10th annual Lupus Luminary Luncheon for Science honored the accomplishments of luminaries transforming lupus and other arenas.

May 7, 2019
·
3 min read
Business

Halozyme Reports First Quarter 2019 Results

Revenue of $56.9 Million Compared to $30.9 Million in Prior-year Period

May 7, 2019
·
8 min read
Business

Varex Imaging Announces Financial Results For Second Quarter Of Fiscal Year 2019

Varex Imaging Corporation announced its financial results for the second quarter of fiscal year 2019.

May 7, 2019
·
12 min read
Deals

Tocagen Reports First Quarter 2019 Financial and Business Results

Tocagen Inc. reported financial results and business highlights for the first quarter ended March 31, 2019.

May 7, 2019
·
6 min read
Deals

Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Audentes Therapeutics, Inc. reported its financial results for the first quarter ended March 31, 2019 and provided an update on the company’s recent achievements and anticipated upcoming milestones.

May 7, 2019
·
11 min read
Deals

Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights

Ardelyx, Inc. reported business highlights and financial results for the first quarter ended March 31, 2019.

May 7, 2019
·
7 min read
Business

Hill-Rom Announces Appointment Of Gregory Moore To Board Of Directors

Hill-Rom Holdings, Inc., announced the appointment of Gregory J. Moore MD, PhD, to its Board of Directors, effective May 7, 2019.

May 7, 2019
·
1 min read
Business

Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States

Heron Therapeutics, Inc. announced they joined the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic.

May 7, 2019
·
5 min read
Business

REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD

Continuing subject recruitment for RGX-121 Phase I/II trial for MPS II, RGX-111 Phase I trial for MPS I and RGX-501 Phase I/II trial for HoFH; interim updates for all trials expected in second half 2019

May 7, 2019
·
17 min read